Public Employees Retirement System of Ohio Sells 4,553 Shares of OraSure Technologies, Inc. $OSUR

Public Employees Retirement System of Ohio reduced its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 4.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 93,379 shares of the medical instruments supplier’s stock after selling 4,553 shares during the period. Public Employees Retirement System of Ohio owned about 0.12% of OraSure Technologies worth $280,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of OSUR. Farther Finance Advisors LLC bought a new position in OraSure Technologies during the second quarter valued at approximately $26,000. Amundi bought a new position in OraSure Technologies during the first quarter valued at approximately $47,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in OraSure Technologies during the first quarter valued at approximately $49,000. Quantbot Technologies LP bought a new position in OraSure Technologies during the first quarter valued at approximately $52,000. Finally, Simplicity Wealth LLC bought a new position in OraSure Technologies during the first quarter valued at approximately $53,000. 93.50% of the stock is currently owned by institutional investors.

OraSure Technologies Stock Up 0.6%

Shares of OSUR stock opened at $3.20 on Tuesday. The stock has a fifty day moving average of $3.13 and a 200 day moving average of $3.04. OraSure Technologies, Inc. has a 52 week low of $2.36 and a 52 week high of $4.60. The firm has a market capitalization of $234.05 million, a price-to-earnings ratio of -4.78 and a beta of 0.46.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of OraSure Technologies in a research note on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $3.00.

OraSure Technologies Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.